- Home
- COKE vs HALO Comparison
COKE vs HALO Comparison
Compare COKE & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COKE | HALO |
|---|---|---|
| Founded | 1902 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 8.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COKE | HALO |
|---|---|---|
| Price | $153.52 | $71.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $76.42 |
| AVG Volume (30 Days) | 548.0K | ★ 1.7M |
| Earning Date | 02-19-2026 | 02-17-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | 22.14 | ★ 56.68 |
| EPS | ★ 7.03 | 4.74 |
| Revenue | ★ $7,070,308,000.00 | $1,242,852,000.00 |
| Revenue This Year | N/A | $34.54 |
| Revenue Next Year | N/A | $26.28 |
| P/E Ratio | $21.78 | ★ $14.87 |
| Revenue Growth | 4.22 | ★ 31.19 |
| 52 Week Low | $105.21 | $47.50 |
| 52 Week High | $169.49 | $79.50 |
Technical Indicators
Market Signals| Indicator | COKE | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 56.01 |
| Support Level | $147.28 | $69.53 |
| Resistance Level | $154.50 | $74.08 |
| Average True Range (ATR) | 3.49 | 2.13 |
| MACD | 0.17 | -0.10 |
| Stochastic Oscillator | 82.00 | 54.90 |
Price Performance
Historical ComparisonAbout COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.